|
⚲
|
| Charles Ryan | |
|---|---|
| Firm | |
| Address | 611 Gateway Boulevard Suite 273 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM ($M) |
|---|---|---|---|---|---|
| Quince Therapeutics Inc | 021-550459 | Executive Officer | 11.5 M of 21.9 M |
||
| Toloka Group Inc | 021-546436 | Director | 72.0 M of 90.0 M |
||
| Applied DNA Sciences Inc | 021-347414 | Director | 0.4 M of 0.4 M |
||
| Applied DNA Sciences Inc | 021-344655 | Director | 1.5 M of 1.5 M |
||
| Fasten Inc | 021-274131 | Director | 10.5 M | ||
| Applied DNA Sciences Inc | 021-252556 | Director | 0.0 M of 5.4 M |
||
| Applied DNA Sciences Inc | 021-225413 | Director | 1.8 M of 1.8 M |
||
| Applied DNA Sciences Inc | 021-219355 | Director | 2.1 M of 2.1 M |
||
| Biorestorative Therapies Inc | 021-213985 | Director | 14.4 M | ||
| ABS Materials Inc | 021-207734 | Director | 3.9 M of 3.9 M |
||
| Applied DNA Sciences Inc | 021-200704 | Director | 7.5 M of 7.5 M |
||
| Applied DNA Sciences Inc | 021-188333 | Director | 2.0 M of 7.5 M |
||
| Applied DNA Sciences Inc | 021-180912 | Director | 1.5 M of 1.5 M |
||
| Almaz Capital Management Ltd | |||||
| Almaz Capital Fund II LP | 021-200077 | Executive Officer | 101.8 M of 101.8 M |
43.0 | |